Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.67 |
| ▸ | PPARA | Q07869 | 4/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.62 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.62 |
| ▸ | LTA4H | P09960 | 3/20 | 0.62 |
| ▸ | LAP3 | P28838 | 1/20 | 0.62 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.58 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2164145 | 1.00 | PPARG (0.67) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL287969 | 1.00 | PPARG (0.67) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL14501335 | 0.88 | MAOB (0.60) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL27854776 | 0.88 | LTA4H (0.71) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL4756304 | 0.87 | PPARG (0.57) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL7801265 | 0.87 | PPARA (0.70) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL5309375 | 0.85 | LTA4H (0.72) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL10272384 | 0.85 | ALOX5 (0.58) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL6732617 | 0.85 | LTA4H (0.72) | PPARGPPARAFFAR1FFAR4LTA4H | |
| SCHEMBL2164928 | 0.85 | LTA4H (0.72) | PPARGPPARAFFAR1FFAR4LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12168648-B2 | Opioid receptor modulators | EPIODYNE, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| US-20240092746-A1 | OPIOID RECEPTOR MODULATORS | EPIODYNE, INC. | 2024-03-21 | — | — | US | disclosed |
| EP-4320105-A1 | OPIOID RECEPTOR MODULATORS | Epiodyne, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| CN-117425644-A | Opioid receptor modulators | 埃皮欧黛公司 | 2024-01-19 | — | — | CN | disclosed |
| US-11634396-B2 | Opioid receptor modulators | EPIODYNE, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-20220356157-A1 | OPIOID RECEPTOR MODULATORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-11-10 | — | — | US | disclosed |
| WO-2022216750-A1 | OPIOID RECEPTOR MODULATORS | EPIODYNE, INC. (US) | 2022-10-13 | — | — | WO | disclosed |
| US-20220023262-A1 | COMPOSITION COMPRISING HIGH PURITY PYRROLE DERIVATIVE AND METHOD FOR PREPARATION THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2022-01-27 | — | — | US | disclosed |
| EP-3004053-B1 | A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES | CADILA HEALTHCARE LTD (IN) | 2021-03-24 | — | — | EP | disclosed |
| EP-3024816-B1 | PPAR-SPARING COMPOUNDS FOR THE TREATMENT OF METABOLIC DISEASES | METABOLIC SOLUTIONS DEV CO LLC (US) | 2020-06-03 | — | — | EP | disclosed |
| WO-2003027084-A1 | IMPROVED PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE PHENOXAZINE DERIVATIVES AS ANTIDIABETIC AGENTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-04-03 | — | — | WO | disclosed |
| US-6531596-B1 | S(-)-2-methoxy-3-(4-(2-(phenoxazin-10-yl)methoxy) phenyl)propionic acid; benzylating p-hydroxybenzaldehyde or tyrosine; reaction with phenoxazinyl mesylate | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-03-11 | — | — | US | disclosed |
| WO-2003010157-A1 | DIOXANE DERIVATIVES AND A PROCESS FOR THEIR PREPARATION | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003008362-A1 | NOVEL 3-ARYL-2-HYDROXY PROPANOL DERIVATIVES AND A PROCESS FOR THEIR PREPARATION | DR. REDDY'S LABORATORIES LTD (IN) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003002550-A1 | DIOXALANE DERIVATIVES AND A PROCESS FOR THEIR PREPARATION | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002100813-A2 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | ELI LILLY AND COMPANY (US) | 2002-12-19 | — | — | WO | disclosed |
| US-20020177726-A1 | Process for the preparation of 3-aryl-2-hydroxy propanoic acid | DR. REDDY'S RESEARCH FOUNDATION | 2002-11-28 | — | — | US | disclosed |
| WO-2002024625-A2 | PROCESS FOR THE PREPARATION OF 3-ARYL-2-HYDROXY PROPANOIC ACID DERIVATIVES | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2002-03-28 | — | — | WO | disclosed |
| EP-1124808-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF NEW ANTIDIABETIC AGENTS | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000026200-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF NEW ANTIDIABETIC AGENTS | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092746-A1 | OPIOID RECEPTOR MODULATORS | OPRM1, OPRK1, OPRL1 | PPARG 395/4885PPARA 506/4885FFAR1 235/4885 |
| US-12168648-B2 | Opioid receptor modulators | OPRM1, OPRK1, OPRL1 | PPARG 395/4885PPARA 506/4885FFAR1 235/4885 |
| US-11634396-B2 | Opioid receptor modulators | OPRM1, OPRK1, OPRL1 | PPARG 395/4885PPARA 506/4885FFAR1 235/4885 |
| US-20220356157-A1 | OPIOID RECEPTOR MODULATORS | OPRM1, OPRK1, OPRL1 | PPARG 395/4885PPARA 506/4885FFAR1 235/4885 |
| US-20020177726-A1 | Process for the preparation of 3-aryl-2-hydroxy propanoic acid | HPD, HAO1, HAAO | PPARG 772/4885PPARA 265/4885FFAR1 75/4885 |
| US-20220023262-A1 | COMPOSITION COMPRISING HIGH PURITY PYRROLE DERIVATIVE AND METHOD FOR PREPARATION THEREOF | DHPS, OGFOD1, OGDH | PPARG 1578/4885PPARA 1843/4885FFAR1 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.